Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Cancer Medicine
|
March 27, 2025
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
Benjamin D Mercier, Ameish Govindarajan, Daniela V Castro, et al.
European Urology Focus
|
December 8, 2024
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
Justine Panian, Caiwei Zhong, Sharon H Choi, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
Hedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, et al.
European Urology Oncology
|
January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
Zeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Cancers
|
June 12, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability
Koral U Shah, Daniela V Castro, Xiaochen Li, et al.
BJU International
|
August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy
Daniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Cancer Cell
|
August 8, 2025
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Nicholas J Salgia, Adil Khan, Wilhelm M Aubrecht, et al.
Archives of Iranian Medicine
|
July 27, 2017
Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015
Sadaf G Sepanlou, Mahboubeh Parsaeian, Kristopher J Krohn, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Cancer Medicine
|
March 27, 2025
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
Benjamin D Mercier, Ameish Govindarajan, Daniela V Castro, et al.
European Urology Focus
|
December 8, 2024
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
Justine Panian, Caiwei Zhong, Sharon H Choi, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
Hedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, et al.
European Urology Oncology
|
January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
Zeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Cancers
|
June 12, 2026
Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability
Koral U Shah, Daniela V Castro, Xiaochen Li, et al.
BJU International
|
August 7, 2023
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy
Daniela V Castro, Sweta R Prajapati, Matthew I Feng, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Cancer Cell
|
August 8, 2025
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Nicholas J Salgia, Adil Khan, Wilhelm M Aubrecht, et al.
Archives of Iranian Medicine
|
July 27, 2017
Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015
Sadaf G Sepanlou, Mahboubeh Parsaeian, Kristopher J Krohn, et al.
Page
of 5